Long‐term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open‐label extension study
Christopher H. van Dyck, Reisa Anne Sperling, Keith A. Johnson, Shobha Dhadda, Michio Kanekiyo, David Li, Michelle Gee, Steven M. Hersch, Michael C. Irizarry, Lynn Darden Kramer
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1002/alz.70905
- Published
- Dec 1, 2025
- Venue
- Alzheimer s & Dementia
- DOI
- 10.1002/alz.70905
- PubMed
- 41355080
- Categories
- Alzheimer's disease research and treatments
- License
- cc-by-nc
- Provenance
- openalex